If you have diabetic kidney disease (chronic kidney disease), the REACT Study, a kidney disease medical research study, may help restore your kidney function and delay or avoid dialysis or a kidney transplant. The purpose of this medical research study is to assess the safety and effectiveness of NKA (Neo-Kidney Augment) cell therapy in patients with type 2 diabetes and chronic kidney disease.
More details on the REACT Study
After you give consent to participate in this kidney disease medical research study, you will have a medical visit. This visit will include tests to determine if you meet the specific eligibility criteria to participate. If you meet the criteria, a kidney biopsy, which is a standard medical procedure to collect a small piece of kidney tissue, will be performed within 60 days after your initial screening visit. If the biopsy collects enough healthy kidney cells to develop the investigational medication (NKA), you will then be enrolled in the study.
Once you’ve been enrolled in the study, you will receive at least two injections of the NKA cell therapy once or twice a year over the course of the study. The physicians conducting the study will give regular physical exams and medical screenings at no charge, and they will monitor your health regularly. You may also continue to see your own doctor over the course of the trial.
Ready to take the first step? Continue to see if you may qualify to participate.
See If You May Qualify